First product issuance by KLDX
KUALA LUMPUR: Kapital DX Sdn Bhd (KLDX), a multi-asset fundraising and investment platform, has announced the issuance of its first product, a RM150mil tokenised primary offering of a syariah-compliant fixed-income product (i-INT Programme) by Integra Healthcare Technology Sdn Bhd.

The programme offers a five-year tenor with a profit rate of up to 10% per annum.

According to KLDX, Tranche 1 of the i-INT Programme, amounting to RM29mil, has been fully subscribed through institutional participation, while Tranche 2 is open for subscription.

It said the venture showcases the transformative potential of blockchain technology in the realm of fundraising and investment.

“Through blockchain technology, KLDX enables fractional ownership of a wide array of assets, making private market investments accessible to a wider audience,” it added.

KLDX founder and chief executive officer Selvarany Rasiah said the issuance demonstrates its commitment to supporting impactful projects that benefit the community.

“Our platform is designed to catalyse economic growth by facilitating accessible, efficient fundraising for businesses and at the same time, offering investors a gateway to diverse, high-yield private market assets.

“We are committed to fostering a vibrant ecosystem where businesses can thrive on robust investments and where investors can achieve superior returns, thereby driving mutual prosperity in our economy.”
Markets
KUALA LUMPUR: Kapital DX Sdn Bhd (KLDX), a multi-asset fundraising and investment platform, has announced the issuance of its first product, a RM150mil tokenised primary offering of a syariah-compliant fixed-income product (i-INT Programme) by Integra Healthcare Technology Sdn Bhd.